Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QuanterixQTRX 58 Days Inventory is 231.36 as of Mar. 2026, which is 93% above its 10-year median of 119.88. GuruFocus rates QTRX with a GF Score™ of 58/100 and a GF Value™ of $11.72 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Quanterix ranks worse than 58.38% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Quanterix's Average Total Inventories for the
three
months ended in Mar. 2026 was $52.9 Mil. Quanterix's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $20.8 Mil.
Hence, Quanterix's Days Inventory for the
three
months ended in Mar. 2026 was 231.36.
The historical rank and industry rank for Quanterix's Days Inventory or its related term are showing as below:
QTRX'
s Days Inventory Range Over the Past 10 Years
Min: 46.94 Med: 119.88 Max: 216.07
Current: 200.26
During the past 11 years, Quanterix's highest Days Inventory was 216.07. The lowest was 46.94. And the median was 119.88.
QTRX's Days Inventory is ranked worse than 58.38% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs QTRX: 200.26
Quanterix's Days Inventory
increased
from Mar. 2025 (187.87) to Mar. 2026 (231.36).
It might indicate that Quanterix's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Quanterix's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.39.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Quanterix's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.45.
Quanterix (NAS:QTRX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Quanterix's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Quanterix's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Quanterix Days Inventory Related Terms
Quanterix Days Inventory Historical Data
* Premium members only.
The historical data trend for Quanterix's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QTRX vs LUCD, INFU, APYX: Days Inventory Comparison
For the Medical Devices subindustry, Quanterix's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quanterix Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Quanterix's Days Inventory distribution charts can be found below:
* The bar in red indicates where Quanterix's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quanterix (QTRX) has a Days Inventory of 231.36 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Quanterix and its competitors. This is 93% above median its historical median of 119.88. Over the past decade, Quanterix's Days Inventory has ranged from 46.94 to 216.07. According to the industry distribution chart, Quanterix ranks #460 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 58.4%.
Is Quanterix's Days Inventory too high?
Quanterix's current Days Inventory of 231.36 is 93% above median its 10-year median of 119.88. Over the past 10 years, this metric has ranged from a low of 46.94 to a high of 216.07. The Medical Devices & Instruments industry median Days Inventory is 179.12. Quanterix's value of 231.36 is 29.2% above this industry median. Based on the distribution chart, Quanterix ranks #460 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Quanterix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Quanterix's Days Inventory compare to LUCD and INFU?
According to the Medical Devices & Instruments industry distribution chart, Quanterix ranks #460 out of 788 companies for Days Inventory. This places Quanterix in the lower half of its industry. The industry median Days Inventory is 179.12. Quanterix's value of 231.36 is 29.2% above this benchmark. Historically, Quanterix's own Days Inventory has ranged from 46.94 to 216.07 over the past decade. While the company's 10-year median is 119.88 vs. the industry median of 179.12, Quanterix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quanterix's current Days Inventory of 231.36 is 29.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Quanterix and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quanterix's current Days Inventory is 231.36, which is 93% above median its own 10-year median of 119.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quanterix stock overvalued right now?
Based on GuruFocus' analysis, Quanterix (QTRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.72, compared to a current price of $3.88 — trading 66.9% below its estimated fair value. The current Days Inventory is 231.36, which is 93% above median its 10-year median of 119.88 and 29.2% above the Medical Devices & Instruments industry median of 179.12. Quanterix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Quanterix (QTRX), the current Days Inventory is 231.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quanterix (QTRX) Overvalued in 2026?
Based on GuruFocus' analysis, Quanterix stock appears to be undervalued.
The current stock price of $3.88 is trading 66.9% below its estimated GF Value™ of $11.72.
GuruFocus considers Quanterix to be Possible Value Trap.
Key valuation signals for QTRX:
Days Inventory: 231.36 (93% above median its 10-year median of 119.88)
GF Value™: $11.72 vs. price of $3.88 (66.9% below fair value)
Industry Position: 29.2% above the Medical Devices & Instruments median (#460 of 788)
No single metric tells the full story. See the QTRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
58GF Score
Get the complete analysis for QTRX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QTRX has been successfully added to your 
